Strategic appointment strengthens clinical leadership 

Qureight has appointed Dr Steven Bishop as its new Chief Medical Officer, reflecting the company’s continued growth and commercial success in supporting global clinical studies.

Previously Chief Data Officer, Dr Bishop will now lead Qureight’s Clinical Operations team and oversee product development, clinical strategy, and regulatory affairs. His appointment comes as the company strengthens its infrastructure and capability to deliver AI-powered imaging biomarkers and clinical data management for lung and heart disease trials worldwide.

Dr Bishop brings over 20 years of experience in healthcare and data science, including leadership roles at CMR Surgical and Flok Health. He has extensive experience in AI and imaging biomarker development, and holds both a medical degree and a computer science background.

Muhunthan Thillai, MD, Co-founder and CEO of Qureight, said: “Steven has been an invaluable member of our leadership team since joining 18 months ago. His new role as CMO reflects both his contributions and the progress of Qureight as we scale our global clinical trial capabilities.”

Dr Bishop added: “I am excited to take on this new role and help Qureight continue to deliver innovative AI-driven solutions that support clinical trials and ultimately improve patient care.”

More information online